AMERIPRISE FINANCIAL INC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 41 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$564,000
-50.8%
22,063
-57.6%
0.00%
Q4 2020$1,146,000
-18.6%
51,992
-33.5%
0.00%
-100.0%
Q3 2020$1,407,000
-29.2%
78,178
-0.1%
0.00%0.0%
Q2 2020$1,988,000
+41.2%
78,278
+2.2%
0.00%0.0%
Q1 2020$1,408,000
-42.5%
76,630
-11.6%
0.00%0.0%
Q1 2014$2,448,00086,6780.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders